Rugby Chest Congestion Relief PE
NDC 0536-1309, Guaifenesin/phenylephrine, tablet, from Rugby Laboratories.
- Product NDC
- 0536-1309
- Status
- Listed
- Labeler
- Rugby Laboratories
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0536-1309 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN400 mg/1
- PHENYLEPHRINE HYDROCHLORIDE10 mg/1
Pharmacologic classes
Adrenergic alpha1-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; alpha-1 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0536-1309-07 | 00536130907 | 1 BOTTLE, PLASTIC in 1 CARTON (0536-1309-07) / 30 TABLET in 1 BOTTLE, PLASTIC |
| 0536-1309-08 | 00536130908 | 1 BOTTLE, PLASTIC in 1 CARTON (0536-1309-08) / 60 TABLET in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
Related lookups
NADAC price for package 00536130908
GET /v1/drugs/nadac/00536130908
Use it
Look up 0536-1309 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0536-1309 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0536-1309. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.